Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pd-1 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06463665
What this trial is testing

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

Who this might be right for
Advanced Non-squamous Non-small-cell Lung CancerAdvanced Squamous Non-Small Cell Lung CarcinomaMetastatic Non-squamous Non Small Cell Lung Cancer+5 more
Genelux Corporation 142
Testing effectiveness (Phase 2)Study completedNCT05057247
What this trial is testing

Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck (SCCHN)Recurrent Squamous Cell Carcinoma of the Head and NeckMetastatic Head and Neck Cancer+2 more
Glenn J. Hanna 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07776340
What this trial is testing

Induction PD-1 Inhibitor and Chemotherapy Followed by Chemoradiotherapy in Unresectable or Inoperable HPV-negative LA-HNSCC

Who this might be right for
HPV-unrelated Head and Neck Squamous Cell Carcinoma
Fudan University 104
Not applicableStudy completedNCT05332821
What this trial is testing

TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 1,244
Testing effectiveness (Phase 2)Looking for participantsNCT05214222
What this trial is testing

Penpulimab Plus Chemotherapy With/Without Anlotinib for Patients With Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Advanced Esophageal Squamous Cell Carcinoma
Nanfang Hospital, Southern Medical University 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07537972
What this trial is testing

Denosumab Strategy for Liver Cancer With Bone Metastases

Who this might be right for
Hepatocellular Carcinoma (HCC)Bone Metastases
Tongji Hospital 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT07257575
What this trial is testing

Controlled Study of Serplulimab Combined With Chemotherapy for Locally Advanced Gastric Adenocarcinoma

Who this might be right for
Gastric Cancer Stage III
Guangdong Provincial People's Hospital 138
Testing effectiveness (Phase 2)UnknownNCT04809779
What this trial is testing

PD-1 Inhibitor Concurrent With Chemotherapy as Neoadjuvant Therapy for TNBC

Who this might be right for
Triple Negative Breast Cancer
First Affiliated Hospital, Sun Yat-Sen University 49
Testing effectiveness (Phase 2)Looking for participantsNCT06006650
What this trial is testing

Neoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous Cell

Who this might be right for
NeoadjuventPD-1 InhibitorChemotherapy+1 more
Tang-Du Hospital 114
Not applicableLooking for participantsNCT07359040
What this trial is testing

Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerNeoadjuvant TherapyPD-1 Inhibitors+1 more
Peking University People's Hospital 80
Testing effectiveness (Phase 2)UnknownNCT04146831
What this trial is testing

Sintilimab in FH-deficient Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaFH-deficientSintilimab
West China Hospital 37
Testing effectiveness (Phase 2)UnknownNCT05757466
What this trial is testing

Prolgolimab Monotherapy or in Combination With Bendamustine for r/r Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
St. Petersburg State Pavlov Medical University 30
Testing effectiveness (Phase 2)Ended earlyNCT03354962
What this trial is testing

Induction of Immune-mediated aBscOpal Effect thrOugh STEreotactic Radiation Therapy in Metastatic Melanoma Patients Treated by PD-1 + CTLA-4 Inhibitors (BOOSTER MELANOMA)

Who this might be right for
Melanoma
Institut Claudius Regaud 6
Testing effectiveness (Phase 2)Study completedNCT04735861
What this trial is testing

Sintilimab Plus Bevacizumab in Recurrent/Persistent Ovarian Clear Cell Carcinoma

Who this might be right for
Ovarian Clear Cell Carcinoma
Tongji Hospital 38
Not applicableUnknownNCT06461936
What this trial is testing

Intra-Tumoral Vascular Growth Patterns is a Robust Indicator of Adjuvant Therapy Following Liver Resection in HCC

Who this might be right for
HCCAdjuvant TherapyImmunotherapy+1 more
Chen Xiaoping 620
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07381400
What this trial is testing

Neoadjuvant mFOLFOX6 Chemotherapy Combined With Anti-PD-1 Therapy in MSS/pMMR Locally Advanced Rectal Cancer (FIRM02 Study)

Who this might be right for
Rectal Cancer
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 128
Testing effectiveness (Phase 2)Looking for participantsNCT07786766
What this trial is testing

Pemigatinib Plus PD-1 Inhibitor With or Without Chemotherapy in FGFR2 Fusion/Rearrangement-Positive Cholangiocarcinoma

Who this might be right for
Biliary Tract Cancer (BTC)
Haitao Zhao, MD 154
Early research (Phase 1)Active Not RecruitingNCT03843294
What this trial is testing

Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma

Who this might be right for
Hodgkin LymphomaDiffuse Large B Cell Lymphoma
Catherine Bollard 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07656766
What this trial is testing

Sintilimab Plus Gossypol Acetate in Advanced Colorectal Cancer

Who this might be right for
Advanced Colorectal Cancer
Peking University People's Hospital 32
Testing effectiveness (Phase 2)Looking for participantsNCT06802757
What this trial is testing

Posaconazole Plus PD-1 Inhibitors and Chemotherapy vs PD-1 Inhibitors and Chemotherapy in Neoadjuvant Therapy for Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Shandong Cancer Hospital and Institute 72
Next Page